1.Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.
Jae Hyeok CHOI ; Jong Won KIM ; Joo Yong LEE ; Woong Kyu HAN ; Koon Ho RHA ; Young Deuk CHOI ; Sung Joon HONG ; Young Eun YOON
Korean Journal of Urology 2015;56(10):695-702
PURPOSE: To investigate and distinguish the computed tomography (CT) characteristics of chromophobe renal cell carcinoma (chRCC) and renal oncocytoma. MATERIALS AND METHODS: Fifty-one patients with renal oncocytoma and 120 patients with chRCC, diagnosed by surgery between November 2005 and June 2015, were studied retrospectively. Two observers, who were urologists and unaware of the pathological results, reviewed the preoperative CT images. The tumors were evaluated for size, laterality, tumor type (ball or bean pattern), central stellate scar, segmental enhancement inversion, and angular interface pattern and tumor complexity. To accurately analyze the mass-enhancing pattern of renal mass, we measured Hounsfield units (HUs) in each phase and analyzed the mean, maximum, and minimum HU values and standard deviations. RESULTS: There were 51 renal oncocytomas and 120 chRCCs in the study cohort. No differences in clinical and demographic characteristics were observed between the two groups. A central stellate scar and segmental enhancement inversion were more likely in oncocytomas. However, there were no differences in ball-/bean-type categorization, enhancement pattern, and the shape of the interface between the groups. Higher HU values tended to be present in the corticomedullary and nephrogenic phases in oncocytomas than in chRCC. Receiver-operating characteristic curve analysis showed that the presence of a central stellate scar and higher mean HU values in the nephrogenic phase were highly predictive of renal oncocytoma (area under the curve=0.817, p<0.001). CONCLUSIONS: The appearance of a central stellate scar and higher mean HU values in the nephrogenic phase could be useful to distinguish renal oncocytomas from chRCCs.
Adenoma, Oxyphilic/pathology/*radiography
;
Carcinoma, Renal Cell/pathology/*radiography
;
Diagnosis, Differential
;
Female
;
Humans
;
Kidney Neoplasms/pathology/*radiography
;
Male
;
Middle Aged
;
Retrospective Studies
;
Tomography, X-Ray Computed
2.Renal cryoablation of small renal masses: A Korea University experience.
Hyung Keun KIM ; Jong Hyun PYUN ; Jae Yoon KIM ; Seung Bin KIM ; Seok CHO ; Sung Gu KANG ; Jeong Gu LEE ; Je Jong KIM ; Jun CHEON ; Seok Ho KANG
Korean Journal of Urology 2015;56(2):117-124
PURPOSE: To evaluate the perioperative, functional, and oncological outcomes of renal cryoablation (RC) of small renal masses (SRMs) performed in Korea University Hospital. MATERIALS AND METHODS: We reviewed an Institutional Review Board-approved database of 70 patients who underwent RC and were followed up for a minimum of 3 months by a single surgeon in Korea University Hospital from August 2007 to May 2014. Among these patients, 68 patients (79 renal masses) were enrolled in our research. We evaluated perioperative, functional, and oncologic outcomes of RC. RESULTS: A total of 68 patients (79 renal masses) underwent RC in our institution. The mean age of the patients was 62.0 years. The mean tumor size was 2.25 cm. Among the 59 patients who underwent laparoscopic surgery, only 1 patient (1.47%) was converted to open surgery. No other perioperative complications occurred. The mean preoperative and 1-month postoperative estimated glomerular filtration ratio (eGFR) were 71.8 and 68.3 mL/min/1.73 m2, respectively (p=0.19). The mean 1-year postoperative eGFR was 65.0 mL/min/1.73 m2 (p=0.25). The mean follow-up period was 59.76 months (range, 3-119 months). Local tumor recurrence occurred in eight tumors (15.4%; a total of 52 renal cell carcinomas). Concerning treatment in the patients with recurrence, five patients underwent re-treatment and three patients are under active surveillance. None of the eight patients who experienced local recurrence had additional recurrence or tumor progression during the follow-up period. In our study, the recurrence-free rate was 83.0% and the cancer-specific survival rate was 100%. Moreover, the 5- and 10-year overall survival rates were both 100%. CONCLUSIONS: Long-term experience with RC in our institution demonstrates that RC is a safe and effective treatment for patients with SRMs.
Adult
;
Aged
;
Aged, 80 and over
;
Biopsy
;
Carcinoma, Renal Cell/pathology/radiography/*surgery
;
Cryosurgery/adverse effects/*methods
;
Follow-Up Studies
;
Glomerular Filtration Rate
;
Humans
;
Kidney Neoplasms/pathology/radiography/*surgery
;
Laparoscopy/adverse effects/methods
;
Middle Aged
;
Neoplasm Recurrence, Local
;
Tomography, X-Ray Computed
;
Treatment Outcome
;
Young Adult
3.Unusual Malignant Solid Neoplasms of the Kidney: Cross-Sectional Imaging Findings.
Ali Devrim KARAOSMANOGLU ; Mehmet Ruhi ONUR ; Ali SHIRKHODA ; Mustafa OZMEN ; Peter F HAHN
Korean Journal of Radiology 2015;16(4):853-859
Malignant kidney neoplasms are the most frequently encountered solid kidney masses. Although renal cell carcinoma is the major renal malignancy, other solid malignant renal masses should be considered in the differential diagnosis of solid renal masses that do not contain a macroscopic fatty component. In this pictorial essay, we present the imaging findings of a primitive neuroectodermal tumor, primary liposarcoma of the kidney, primary neuroendocrine tumor, leiomyosarcoma, synovial sarcoma, malignant fibrous histiocytoma, sclerosing fibrosarcoma and renal metastasis of osteosarcoma.
Bone Neoplasms/secondary
;
Carcinoma, Renal Cell/pathology/radiography
;
Diagnosis, Differential
;
Fibrosarcoma/radiography
;
Histiocytoma/radiography
;
Humans
;
Kidney Neoplasms/*pathology/radiography
;
Leiomyosarcoma/pathology/radiography
;
Magnetic Resonance Imaging
;
Middle Aged
;
Neuroectodermal Tumors, Primitive/pathology/radiography
;
Osteosarcoma/pathology
;
Sarcoma
;
Sarcoma, Synovial/radiography
;
Tomography, X-Ray Computed
4.Imaging Findings of Common Benign Renal Tumors in the Era of Small Renal Masses: Differential Diagnosis from Small Renal Cell Carcinoma: Current Status and Future Perspectives.
Korean Journal of Radiology 2015;16(1):99-113
The prevalence of small renal masses (SRM) has risen, paralleling the increased usage of cross-sectional imaging. A large proportion of these SRMs are not malignant, and do not require invasive treatment such as nephrectomy. Therefore, differentation between early renal cell carcinoma (RCC) and benign SRM is critical to achieve proper management. This article reviews the radiological features of benign SRMs, with focus on two of the most common benign entities, angiomyolipoma and oncocytoma, in terms of their common imaging findings and differential features from RCC. Furthermore, the role of percutaneous biopsy is discussed as imaging is yet imperfect, therefore necessitating biopsy in certain circumstances to confirm the benignity of SRMs.
Abdominal Fat/pathology
;
Adenoma, Oxyphilic/diagnosis/radiography/ultrasonography
;
Angiomyolipoma/diagnosis/radiography/ultrasonography
;
Carcinoma, Renal Cell/*diagnosis/radiography/ultrasonography
;
Diagnosis, Differential
;
Humans
;
Kidney Neoplasms/*diagnosis/*radiography/ultrasonography
;
Leiomyoma/diagnosis/radiography/ultrasonography
5.Renal Pelvic Urothelial Carcinoma With Vena Caval Thrombus Mimicking Renal Cell Carcinoma.
Richilda Red DIAZ ; Jong Kyou KWON ; Joo Yong LEE ; Ji Hae NAHM ; Kang Su CHO ; Won Sik HAM ; Nam Hoon CHO ; Young Deuk CHOI
Korean Journal of Urology 2014;55(9):624-627
A 61-year-old man presented with a right renal mass with a vena caval thrombus on computed tomography that was consistent with renal cell carcinoma. The results of routine laboratory examinations and urinalysis were within normal limits. Preoperative planning was critical owing to the presence of the vena caval thrombus. A radical nephrectomy, vena caval thrombectomy, and regional lymphadenectomy were done. The pathologic report was consistent with a high-grade, invasive urothelial carcinoma, with sarcomatoid differentiation involving the renal vein and inferior vena cava (Stage IV, T4N0M0). Thus, this was a rare case of upper tract urothelial carcinoma. Adjuvant chemotherapy with the methotrexate, vinblastine, doxorubicin, cisplatinum regimen is scheduled. To our knowledge, this is the first report in Korea of upper tract urothelial carcinoma of the sarcomatoid type with a vena caval thrombus.
Carcinoma, Renal Cell/pathology
;
Diagnosis, Differential
;
Humans
;
Kidney Neoplasms/diagnosis/*pathology
;
Lymph Node Excision/methods
;
Male
;
Middle Aged
;
Nephrectomy/methods
;
Renal Veins/*radiography
;
Thrombectomy/methods
;
Thrombosis/*radiography
;
Tomography, X-Ray Computed
;
Vena Cava, Inferior/*radiography
6.Renal Pelvic Urothelial Carcinoma With Vena Caval Thrombus Mimicking Renal Cell Carcinoma.
Richilda Red DIAZ ; Jong Kyou KWON ; Joo Yong LEE ; Ji Hae NAHM ; Kang Su CHO ; Won Sik HAM ; Nam Hoon CHO ; Young Deuk CHOI
Korean Journal of Urology 2014;55(9):624-627
A 61-year-old man presented with a right renal mass with a vena caval thrombus on computed tomography that was consistent with renal cell carcinoma. The results of routine laboratory examinations and urinalysis were within normal limits. Preoperative planning was critical owing to the presence of the vena caval thrombus. A radical nephrectomy, vena caval thrombectomy, and regional lymphadenectomy were done. The pathologic report was consistent with a high-grade, invasive urothelial carcinoma, with sarcomatoid differentiation involving the renal vein and inferior vena cava (Stage IV, T4N0M0). Thus, this was a rare case of upper tract urothelial carcinoma. Adjuvant chemotherapy with the methotrexate, vinblastine, doxorubicin, cisplatinum regimen is scheduled. To our knowledge, this is the first report in Korea of upper tract urothelial carcinoma of the sarcomatoid type with a vena caval thrombus.
Carcinoma, Renal Cell/pathology
;
Diagnosis, Differential
;
Humans
;
Kidney Neoplasms/diagnosis/*pathology
;
Lymph Node Excision/methods
;
Male
;
Middle Aged
;
Nephrectomy/methods
;
Renal Veins/*radiography
;
Thrombectomy/methods
;
Thrombosis/*radiography
;
Tomography, X-Ray Computed
;
Vena Cava, Inferior/*radiography
7.CT Findings of Gallbladder Metastases: Emphasis on Differences According to Primary Tumors.
Won Seok CHOI ; Se Hyung KIM ; Eun Sun LEE ; Kyoung Bun LEE ; Won Jae YOON ; Cheong Il SHIN ; Joon Koo HAN
Korean Journal of Radiology 2014;15(3):334-345
OBJECTIVE: To describe computed tomography (CT) features of metastatic gallbladder (GB) tumors (MGTs) from various primary tumors and to determine whether there are differential imaging features of MGTs according to different primary tumors. MATERIALS AND METHODS: Twenty-one patients who had pathologically confirmed MGTs and underwent CT were retrospectively enrolled. Clinical findings including presenting symptoms, type of surgery, and interval between primary and metastatic tumors were recorded. Histologic features of primary tumor and MGTs including depth of invasion were also reviewed. Imaging findings were analyzed for the location and morphology of MGTs, pattern and degree of enhancement, depth of invasion, presence of intact overlying mucosa, and concordance between imaging features of primary and metastatic tumors. Significant differences between the histologies of MGTs and imaging features were determined. RESULTS: The most common primary tumor metastasized to the GB was gastric cancer (n = 8), followed by renal cell carcinoma (n = 4) and hepatocellular carcinoma (n = 3). All MGTs (n = 21) manifested as infiltrative wall thickenings (n = 15) or as polypoid lesions (n = 6) on CT, similar to the features of primary GB cancers. There were significant differences in the morphology of MGTs, enhancement pattern, enhancement degree, and depth of invasion according to the histology of primary tumors (p < 0.05). Metastatic adenocarcinomas of the GB manifested as infiltrative and persistently enhancing wall thickenings, while non-adenocarcinomatous metastases usually manifested as polypoid lesions with early wash-in and wash-out. CONCLUSION: Although CT findings of MGTs are similar to those of primary GB cancer, they are significantly different between the various histologies of primary tumors.
Adenocarcinoma/pathology/radiography/secondary
;
Adult
;
Aged
;
Carcinoma, Hepatocellular/pathology/radiography/secondary
;
Carcinoma, Renal Cell/pathology/radiography/secondary
;
Carcinoma, Squamous Cell/pathology/radiography/secondary
;
Diagnosis, Differential
;
Female
;
Gallbladder Neoplasms/pathology/*radiography/*secondary
;
Humans
;
Kidney Neoplasms/pathology
;
Liver Neoplasms/pathology
;
Male
;
Melanoma/pathology/radiography/secondary
;
Middle Aged
;
Neoplasm Invasiveness/radiography
;
Retrospective Studies
;
Stomach Neoplasms/pathology
;
*Tomography, X-Ray Computed
8.Unclassified Mucinous Renal Cell Carcinoma: A Rare Histopathological Entity.
Omer A RAHEEM ; Elana GODEBU ; Seth A COHEN ; Ahmed SHABAIK ; J Kellogg PARSONS
Korean Journal of Urology 2014;55(10):690-692
Renal cell carcinoma (RCC) with mucin production is extremely rare. We present the case of a previously healthy 76-year-old woman who underwent a robotic-assisted laparoscopic right nephrectomy for a 5-cm heterogeneously enhancing right renal mass. Pathology revealed mucin-producing epithelial RCC. We discuss the presentation and pathological features of this case and comment on its definitive treatment.
Adenocarcinoma, Mucinous/*pathology/radiography/surgery
;
Aged
;
Carcinoma, Renal Cell/*pathology/radiography/surgery
;
Female
;
Humans
;
Kidney Neoplasms/*pathology/radiography/surgery
;
Nephrectomy/methods
;
Robotic Surgical Procedures/methods
;
Tomography, X-Ray Computed
9.Interventional Management of a Renal Cell Carcinoma by Radiofrequency Ablation with Tagging and Cooling.
Andreas H MAHNKEN ; Tobias PENZKOFER ; Philipp BRUNERS ; Rolf W GUNTHER ; Bernhard BREHMER
Korean Journal of Radiology 2009;10(5):523-526
Over the last few years, percutaneous radiofrequency (RF) ablation has been successfully established as a viable treatment modality for small peripheral renal cell carcinoma (RCC). This technique is limited by central tumor location and tumor size. We report the interventional management of a 5.3 cm mixed RCC with central and exophytic parts by combining the RF ablation with embolization, tagging, and retrograde, as well as anterograde cooling. The potential pitfalls of complex hybrid interventions for treating RCC are discussed.
Aged
;
Biopsy
;
Carcinoma, Renal Cell/pathology/radiography/*surgery
;
*Catheter Ablation
;
Female
;
Humans
;
Incidental Findings
;
Iodized Oil/therapeutic use
;
Kidney Neoplasms/pathology/radiography/*surgery
;
Tomography, X-Ray Computed
;
Ultrasonography, Interventional
10.Spontaneous Regression of Pulmonary and Adrenal Metastases Following Percutaneous Radiofrequency Ablation of a Recurrent Renal Cell Carcinoma.
Heejung KIM ; Byung Kwan PARK ; Chan Kyo KIM
Korean Journal of Radiology 2008;9(5):470-472
The spontaneous regression of metastatic lesions from renal cell carcinoma (RCC) is extremely rare, but may be encountered following cytoreductive treatments. We report a case of a recurrent RCC with multiple metastatic lesions which spontaneously regressed after undergoing radiofrequency ablation of the renal tumor.
Adrenal Gland Neoplasms/radiography/*secondary
;
Aged, 80 and over
;
Carcinoma, Renal Cell/radiography/*secondary/*surgery
;
*Catheter Ablation
;
Humans
;
Kidney Neoplasms/*pathology/radiography/*surgery
;
Lung Neoplasms/radiography/*secondary
;
Male
;
Neoplasm Recurrence, Local
;
Remission, Spontaneous
;
Tomography, X-Ray Computed

Result Analysis
Print
Save
E-mail